The last time I wrote about Mind Medicine (MindMed) Inc. (MNMD) was when it was gearing up to report results from a phase 2b study known as MMED008, which was using its drug MM120 for the treatment of ...
MELBOURNE, Australia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique ...
Smartphone-based cognitive-behavioral therapy outperforms psychoeducation for generalized anxiety disorder, with benefits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback